Astellas Pharma to develop KateTx’s investigational gene therapy KT430
The Japanese drugmaker will obtain an exclusive global license to develop, manufacture and commercialise KT430, for an undisclosed…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Jun 23
The Japanese drugmaker will obtain an exclusive global license to develop, manufacture and commercialise KT430, for an undisclosed…
09 Jun 23
Initially, the partnership will aim to synthesize and assess ADCs related to cryptophycins, an antitumor molecule, which will…
09 Jun 23
Under the partnership, Charles River will use its contract development and manufacturing organisation expertise in HQ plasmid DNA…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Jun 23
Under the new agreement, Samsung Biologics will offer Pfizer access to supplementary capacity for large-scale manufacturing purposes
09 Jun 23
Under the agreement, AstraZeneca will harness Quell's distinctive arsenal of Treg cell engineering modules, which includes the groundbreaking…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Jun 23
Certest, a company specialized in the development, manufacturing, and commercialization of solutions for the diagnosis of infectious diseases,…
08 Jun 23
The EC authorisation follows the positive recommendation by the European Medicines Agency’s (EMA) Committee for Medicinal Products for…
08 Jun 23
Invistics’ Flowlytics solution utilises predictive analytics to identify illicit diversion of both controlled and non-controlled medications in patient…
07 Jun 23
Together with its gene therapy unit AskBio, Bayer will access Acuitas’ high-potency ionisable lipid technology and LNP carriers,…
07 Jun 23
The new range of products is intended to help researchers to tap into the potential of birth tissues…